Partial response to carboplatin, etoposide phosphate, and atezolizumab in a pediatric patient with high-grade metastatic tumor with rhabdoid and focal neuroendocrine features

Pediatr Blood Cancer. 2020 Feb;67(2):e28048. doi: 10.1002/pbc.28048. Epub 2019 Nov 13.

¹ Division of Pediatric Hematology/Oncology, University of Alabama at Birmingham, Birmingham, Alabama.
² Division of General Surgery, Louisiana State University, Baton Rouge, Louisiana.
³ Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama.
⁴ Department of Pharmacology and Toxicology, University of Alabama at Birmingham, Birmingham, Alabama.
⁵ Divisions of Hematology/Oncology & Gerontology, Geriatrics, and Palliative Care, University of Alabama at Birmingham, Birmingham, Alabama.
⁶ Department of Pathology and Laboratory Medicine, Children's of Alabama, Birmingham, Alabama.
⁷ Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee.
⁸ Division of Anatomic Pathology, UPMC Children's Hospital, Pittsburgh, Pennsylvania.
⁹ Department of Pediatric Surgery, University of Alabama at Birmingham, Birmingham, Alabama.

No abstract available

Publication types